Jiangsu Sihuan Bioengineering Co., Ltd (SHE:000518)
3.680
-0.100 (-2.65%)
Sep 23, 2026, 3:04 PM CST
SHE:000518 Revenue
Jiangsu Sihuan Bioengineering had revenue of 29.57M CNY in the quarter ending June 30, 2026, a decrease of -78.58%. This brings the company's revenue in the last twelve months to 273.23M, down -2.28% year-over-year. In the year 2025, Jiangsu Sihuan Bioengineering had annual revenue of 344.38M with 69.22% growth.
Revenue (ttm)
273.23M
Revenue Growth
-2.28%
P/S Ratio
13.87
Revenue / Employee
1.18M
Employees
232
Market Cap
3.79B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 344.38M | 140.87M | 69.22% |
| Dec 31, 2024 | 203.52M | -31.90M | -13.55% |
| Dec 31, 2023 | 235.42M | -34.73M | -12.86% |
| Jan 1, 2023 | 270.15M | -80.81M | -23.03% |
| Jan 1, 2022 | 350.96M | -154.44M | -30.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Wuhan Hvsen Biotechnology | 1.72B |
| Hefei Lifeon Pharmaceutical | 1.51B |
| Xiangxue Pharmaceutical | 1.48B |
| Kexing Biopharm | 1.44B |
| Beijing Bohui Innovation Biotechnology Group | 816.14M |
| Landfar Bio-medicine | 660.26M |
| Lifecome Biochemistry | 470.43M |
| Shanghai Model Organisms Center | 457.70M |